RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+27.41%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$2.58B
AUM Growth
+$2.58B
(-1.6%)
Cap. Flow
-$171M
Cap. Flow
% of AUM
-6.65%
Top 10 Holdings %
Top 10 Hldgs %
47.96%
Holding
78
New
7
Increased
10
Reduced
27
Closed
8
Top Buys
| 1 |
Ventyx Biosciences
VTYX
|
$47.7M |
| 2 |
Penumbra
PEN
|
$33.9M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$33.7M |
| 4 |
Stryker
SYK
|
$31.9M |
| 5 |
Pliant Therapeutics
PLRX
|
$30.1M |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$151M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$72.8M |
| 3 |
argenx
ARGX
|
$37.3M |
| 4 |
The Beauty Health Co
SKIN
|
$36.3M |
| 5 |
Centene
CNC
|
$28.7M |
Sector Composition
| 1 | Healthcare | 98.01% |
| 2 | Consumer Staples | 0.96% |
| 3 | Industrials | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Fate Therapeutics
FATE
$120M
| $290M | 11.26% | 12,957,222 | – | – |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $227M | 8.8% | 21,719,191 -439,700 | -2% | -$4.59M |
|
3
Krystal Biotech
KRYS
$4.27B
| $132M | 5.14% | 1,899,545 +1,000 | +0.1% | +$69.7K |
|
|
4
argenx
ARGX
$43.6B
| $98.9M | 3.83% | 280,026 -105,792 | -27% | -$37.3M |
|
|
5
Pliant Therapeutics
PLRX
$101M
| $94.2M | 3.65% | 4,508,204 +1,439,203 | +47% | +$30.1M |
|
6
Xenon Pharmaceuticals
XENE
$2.98B
| $85.6M | 3.32% | 2,370,614 +731,270 | +45% | +$26.4M |
|
7
Beam Therapeutics
BEAM
$1.66B
| $84.5M | 3.28% | 1,772,987 -76,900 | -4% | -$3.66M |
|
8
LivaNova
LIVN
$3.08B
| $78M | 3.03% | 1,536,362 -87,400 | -5% | -$4.44M |
|
|
IGMS
9
DELISTED
IGM Biosciences
IGMS
| $75.8M | 2.94% | 3,334,355 | – | – |
|
|
ONEM
10
DELISTED
1Life Healthcare, Inc. Common Stock
ONEM
| $70.1M | 2.72% | 4,087,625 -434,200 | -10% | -$7.45M |
|
11
Replimune Group
REPL
$422M
| $63M | 2.44% | 3,645,309 | – | – |
|
12
Kymera Therapeutics
KYMR
$2.95B
| $62.6M | 2.43% | 2,876,637 +269,507 | +10% | +$5.87M |
|
|
ISEE
13
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $61M | 2.37% | 3,399,900 +1,881,000 | +124% | +$33.7M |
|
14
Celldex Therapeutics
CLDX
$1.47B
| $55.8M | 2.16% | 1,985,151 -85,137 | -4% | -$2.39M |
|
|
DCPH
15
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $55M | 2.13% | 2,973,029 +1,542,112 | +108% | +$28.5M |
|
16
Akero Therapeutics
AKRO
$3.74B
| $54.2M | 2.1% | 1,591,085 +3,800 | +0.2% | +$129K |
|
|
VERV
17
DELISTED
Verve Therapeutics
VERV
| $51.7M | 2.01% | 1,505,126 -328,421 | -18% | -$11.3M |
|
18
Regenxbio
RGNX
$451M
| $50.7M | 1.97% | 1,917,212 -87,451 | -4% | -$2.31M |
|
|
19
Ventyx Biosciences
VTYX
$171M
| $47.7M | 1.85% | +1,365,000 | New | +$47.7M |
|
|
IMGN
20
DELISTED
Immunogen Inc
IMGN
| $40.9M | 1.58% | 8,548,145 -592,900 | -6% | -$2.83M |
|
21
Nurix Therapeutics
NRIX
$714M
| $39.2M | 1.52% | 3,006,684 | – | – |
|
22
ADC Therapeutics
ADCT
$345M
| $36.2M | 1.4% | 7,512,029 | – | – |
|
23
Zymeworks
ZYME
$1.12B
| $35.5M | 1.38% | 5,765,818 +1,930,000 | +50% | +$11.9M |
|
|
24
Penumbra
PEN
$10.6B
| $33.9M | 1.31% | +178,792 | New | +$33.9M |
|
25
Repare Therapeutics
RPTX
$71.7M
| $32.6M | 1.26% | 2,684,396 -36,600 | -1% | -$444K |
|